Novartis AG is 193.1x more valuable than Tyra Biosciences, Inc. by market capitalization ($293.70 B vs $1.52 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TYRA | NVS |
|---|---|---|
| Market cap | $1.52 B | $293.70 B |
| US-listed rank | #2327 | #46 |
| Net income (latest FY) | -$119.95M | - |
| SEC filings | 396 | 947 |
Novartis AG is 193.1x more valuable than Tyra Biosciences, Inc. by market capitalization ($293.70 B vs $1.52 B).
Full pages: Tyra Biosciences, Inc. and Novartis AG, or browse the full rankings.